logo

For the Inventor, By the Inventor

Valbonne, France

Galderma Research & Development Snc


USPTO Granted Patents = 29

% Expired Patents = 44.8


Forward Citations = 257

Loading Chart...
Loading Chart...

42 inventors (with patents filed for the assignee):

goldMedal Jean-Michel Bernardon (12 out of 86 patents)

silverMedal Philippe Diaz (3 out of 16 patents)

bronzeMedal Darryl Rideout (3 out of 6 patents)

4.  Magnus Pfahl (3 out of 24 patents)

5.  Xian-Ping Lu (3 out of 3 patents)

6.  Hongyue Zhang (3 out of 3 patents)

7.  Laurence Clary (2 out of 37 patents)

8.  Michael Graeber (2 out of 30 patents)

9.  Thibaud Biadatti (2 out of 19 patents)

10.  Jean-Michael Bernardon (2 out of 2 patents)

11.  Bruno Charpentier (2 out of 14 patents)

12.  Jean-Guy Boiteau (1 out of 34 patents)

13.  Braham Shroot (1 out of 98 patents)

14.  Yin Liu (1 out of 7 patents)

15.  Michel Rivier (1 out of 16 patents)


Core Competencies:
Telangiectasia
Acne Treatment
Vitamin D Analogues
Bicyclic Aromatic Compounds
Apoptosis Inducing Derivatives
Dermatological Disorders
PPAR Activators
Natural Products
Cosmetic Compositions
Diarylselenide Compounds
Heteroethynylenic Compounds
Stilbene Compounds

29 patents:

1. 8916562 - Methods and compositions for safe and effective treatment of telangiectasia (2014-12-23),
2. 8784905 - Oil-extracted product of indigo naturalis, and preparation process and uses thereof (2014-07-22),
3. 7964202 - Method for treatment of common acne (2011-06-21),
4. 7838558 - Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders (2010-11-23),
5. 6992095 - Stilbene compounds comprising an adamantyl group, compositions and methods thereof (2006-01-31),
6. 6992094 - Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics (2006-01-31),
7. 6927228 - Biaromatic compound activators of PPARγ-type receptors (2005-08-09),
8. 6924400 - Triaromatic vitamin D analogues (2005-08-02),
9. 6924388 - Bicyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof (2005-08-02),
10. 6921777 - Heteroethynylenic compounds and pharmaceutical and cosmetic compositions containing them (2005-07-26),
11. 6908939 - Biaromatic ligand activators of PPARγ receptors (2005-06-21),
12. 6878842 - Process for the enantioselective synthesis of propargyl alcohol derivatives of R configuration from the racemic mixtures thereof (2005-04-12),
13. 6858647 - Retinoid compounds suited for antibacterial applications (2005-02-22),
14. 6831106 - Vitamin D analogues (2004-12-14),
15. 6825360 - Bicyclic aromatic compounds (2004-11-30),
Company Overview
Galderma Research & Development Snc is a prominent player in the dermatology sector, focusing on the development and manufacturing of innovative medical and aesthetic solutions. The company specializes in a range of products, including prescription medications and over-the-counter treatments, aimed at addressing various skin conditions. With a strong commitment to research and development, Galderma operates primarily in Europe, leveraging advanced technologies to enhance skin health and improve patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

29 Patents

#4 in Valbonne

#743 in France

#22,570 in the World

Valbonne, FR
Valbonne, France

Galderma Research & Development Snc

Forward Citations = 257

42 inventors:

goldMedal Jean-Michel Bernardon (12 out of 86 patents)

silverMedal Philippe Diaz (3 out of 16 patents)

bronzeMedal Darryl Rideout (3 out of 6 patents)

4.  Magnus Pfahl (3 out of 24 patents)

5.  Xian-Ping Lu (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Galderma Research & Development Snc. Retrieved from https://idiyas.com/company/galderma-research-and-development-snc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…